Stem cell therapies for Parkinson’s: updates on the clinical trial pipeline

Stem cell therapies are advancing through clinical trials worldwide and remain some of the most promising candidates for a new Parkinson’s treatment. This research focuses on synthesizing stem cells and transforming them into dopamine neurons to replace those lost during the progression of Parkinson’s. In this webinar, expert speakers Dr. Kwang-Soo Kim and Dr. Agnete Kirkeby share an overview of the field, including where research stands today and what these breakthroughs could mean for people living with Parkinson’s. Watch now to learn more about this cutting-edge area of research. This event was supported by BlueRock Therapeutics.